⌘K

Login Start Free

Home/Filings/4/0001192482-10-000296

4//SEC Filing

LEUTZINGER KURT 4

Accession 0001192482-10-000296

CIK 0001301081other

View on SEC.gov Company Profile

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 4:25 PM ET

Size

8.5 KB

Accession

0001192482-10-000296

Insider Transaction Report

Form 4

Period: 2010-10-14

Pharmasset IncVRUS

LEUTZINGER KURT

Chief Financial Officer

Transactions

Award
Stock Option (Richt to Buy)
2010-10-14+29,500→ 29,500 total
Exercise: $32.33Exp: 2020-10-14→ Common Stock (29,500 underlying)

Footnotes (1)

[F1]25% will vest on the first anniversary of the grant and 6.25% will vest quarterly thereafter for the following 12 quarters.

Documents

2 files

Issuer

Pharmasset Inc

CIK 0001301081

Entity typeother

Related Parties

1

filerCIK 0001211704

Filing Metadata

Form type: 4
Filed: Oct 17, 8:00 PM ET
Accepted: Oct 18, 4:25 PM ET
Size: 8.5 KB

View on SEC.gov